Guru Ownership Trend
Guru Analysis for Castle Biosciences, Inc. (CSTL)
Castle Biosciences, Inc. (CSTL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $20.26 M.
Top institutional holders include Renaissance Technologies (RenTech) and Paul Tudor Jones.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $2.28 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 33.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Castle Biosciences, Inc. (CSTL)
Major holders include Renaissance Technologies (RenTech) ($13.08 M), Paul Tudor Jones ($5.47 M), Cliff Asness ($1.59 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 820,662 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $2.28 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited CSTL. The total reported sell value was $4.65 M.
Yes, 0 managers opened new positions in CSTL, and 3 increased their existing holdings. The total reported buy value was $2.37 M.